GlakoLens

Innovations

A contact lens embedded wireless biosensor for 24-hour intraocular pressure monitoring

Partnering Objectives

  • Improvement of the GlakoLens biosensor production processes (biocompatible & flexible PCBs)
  • Prototype production of the biosensor on flexible substrates using biocompatible materials and processes
  • Develop/Implement biocompatible surface modifications (coating, processing) for producing hydrophilic contact lenses
  • Conduct regulatory product testing and clinical trials

Company Story

GlakoLens is a medical devices company developing innovative biosensors based on proprietary technology and cutting-edge research, first of which is a contact lens embedded wireless intraocular pressure monitoring device. This system will non-invasively monitor intraocular pressure changes for 24 hours in order to provide accurate and detailed information to ophthalmologists, enabling them to successfully manage and prevent progression of ocular hypertension and open-angle glaucoma (ocular hypertension induced vision loss). GlakoLens was founded as a technological spin-off from Boğaziçi University by three distinguished academicians bringing collectively over 40 years of research experience on biosensors, integrated circuits, MEMS and electro-optical systems, cumulatively.

Interested in connecting with GlakoLens or want more information?

Leave us your contact information so we can reach you for the Smart Cities Digital Economy companies networking sessions in London.

Register your interest

Interested in connecting with GlakoLens or want more information?

Leave us your contact information so we can reach you for the Environmental & Agricultural Tech companies networking sessions in London.

Register your interest

Interested in connecting with GlakoLens or want more information?

Leave us your contact information so we can reach you for the Healthcare & Life Sciences companies networking sessions in London.

Register your interest

Supported By